Illumina, Inc.
General ticker "ILMN" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $16.1B (TTM average)
Illumina, Inc. follows the US Stock Market performance with the rate: 58.4%.
Estimated limits based on current volatility of 1.9%: low 128.18$, high 133.13$
Factors to consider:
- Total employees count: 92 as of 2023
- China accounted for 11.9% of revenue in the fiscal year ended 2023-01-01
- US accounted for 57.8% of revenue in the fiscal year ended 2023-01-01
- Current price 13.2% below estimated low
- Earnings for 12 months up through Q4 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-29 to 2026-12-29
- 2024-12-29 to 2025-12-29 estimated range: [144.72$, 218.39$]
- 2025-12-29 to 2026-12-29 estimated range: [147.78$, 223.15$]
Financial Metrics affecting the ILMN estimates:
- Negative: with PPE of 56.2 at the end of fiscal year the price was high
- Negative: negative Operating income
- Positive: 19.40 < Shareholder equity ratio, % of 37.65 <= 42.68
- Positive: Industry inventory ratio change (median), % of -0.48 <= -0.16
- Positive: Interest expense per share per price, % of 0.46 <= 0.73
- Positive: 0.01 < Operating cash flow per share per price, % of 3.83
- Positive: -4.43 < Investing cash flow per share per price, % of -0.81
- Negative: Industry earnings per price (median), % of -0.96 <= 0
Short-term ILMN quotes
Long-term ILMN plot with estimates
Financial data
| YTD | 2023-01-01 | 2023-12-31 | 2024-12-29 |
|---|---|---|---|
| Operating Revenue | $3,965.00MM | $4,484.00MM | $4,372.00MM |
| Operating Expenses | $8,144.00MM | $5,553.00MM | $5,205.00MM |
| Operating Income | $-4,179.00MM | $-1,069.00MM | $-833.00MM |
| Non-Operating Income | $-157.00MM | $-48.00MM | $-346.00MM |
| Interest Expense | $26.00MM | $77.00MM | $100.00MM |
| R&D Expense | $1,321.00MM | $1,354.00MM | $1,169.00MM |
| Income(Loss) | $-4,336.00MM | $-1,117.00MM | $-1,179.00MM |
| Taxes | $68.00MM | $44.00MM | $44.00MM |
| Profit(Loss)* | $-4,404.00MM | $-1,161.00MM | $-1,223.00MM |
| Stockholders Equity | $6,599.00MM | $5,745.00MM | $2,373.00MM |
| Inventory | $568.00MM | $587.00MM | $547.00MM |
| Assets | $12,252.00MM | $10,111.00MM | $6,303.00MM |
| Operating Cash Flow | $392.00MM | $478.00MM | $837.00MM |
| Capital expenditure | $286.00MM | $195.00MM | $128.00MM |
| Investing Cash Flow | $-591.00MM | $-231.00MM | $-178.00MM |
| Financing Cash Flow | $1,000.00MM | $-1,210.00MM | $-570.00MM |
| Earnings Per Share** | $-28.05 | $-7.35 | $-7.69 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.